News
Peer-reviewed journals rejected their followup study on the 2023-2024 formulation of mRNA vaccines against the JN.1 variant ...
A groundbreaking study published in the International Journal of Cardiovascular Research & Innovation reveals alarming long-term heart risks linked to COVID-19 mRNA vaccines, challenging official ...
Acute revelations are emerging related to the mRNA COVID shots, raising serious concerns about their safety and long-term effects. A recent study titled "Association Between COVID-19 Vaccination and ...
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...
mRNA technology is the basis for COVID- and other vaccines and could play a role in cancer treatment. Already, researchers across several fields, including LGBTQ+ health and gender identity ...
A new mRNA vaccine could prevent pancreatic cancer from returning — potentially for the long haul. In a small clinical trial, some patients who received the vaccine remained cancer-free for more ...
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Trust in vaccines fell again in 2025 as the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results